Johan Nordgren1, Sumit Sharma1, Filemon Bucardo2, Waqas Nasir3, Gökçe Günaydın4, Djeneba Ouermi5, Leon W Nitiema5, Sylvia Becker-Dreps6, Jacques Simpore5, Lennart Hammarström4, Göran Larson3, Lennart Svensson1. 1. Division of Molecular Virology, Department of Clinical and Experimental Medicine, Medical Faculty, Linköping University, Sweden. 2. Department of Microbiology, University of León, Nicaragua. 3. Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska Academy at the University of Gothenburg. 4. Department of Laboratory Medicine, Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Stockholm, Sweden. 5. Centre de Recherche Biomoléculaire Pietro Annigoni Saint Camille CERBA/LABIOGENE, Université de Ouagadougou, Burkina Faso. 6. Department of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill.
Abstract
BACKGROUND: The live oral rotavirus (RV) vaccines have shown a reduced efficacy in Africa. Recent in vitro studies have shown binding of the RV surface protein (VP4) to histo-blood group antigens (HBGAs) in an RV genotype-dependent manner, suggesting them to be putative receptors for RV. The diversity of HBGA phenotypes in different ethnic populations, combined with prevalence/absence of specific RV genotypes, led us to hypothesize whether the genetic variations in HBGAs in a population limit susceptibility to certain RV genotypes, plausibly leading to reduced vaccine efficacy. METHODS: Association between HBGAs status and susceptibility to RV P genotypes was investigated in children in Burkina Faso and Nicaragua. In total, 242 children with diarrhea in Burkina Faso and Nicaragua were investigated, 93 of whom were RV positive. RESULTS: In Burkina Faso, the P[8] RV strains (n = 27) infected only Lewis- and secretor-positive children (27/27; P < .0001), but no Lewis-negative children. In contrast, the P[6] strains (n = 27) infected predominantly Lewis-negative children (n = 18; P < .0001) but also Lewis-positive children, irrespective of their secretor status. The results from Nicaragua confirmed that all P[8]-infected children (n = 22) were secretor Lewis positive. CONCLUSIONS: As VP4 of genotype P[8] is a component of current RV vaccines, our finding that Lewis-negative children are resistant to P[8] strains provides a plausible explanation for the reduced vaccine efficacy in populations with a high percentage of Lewis-negative individuals, such as in Africa. Furthermore, our findings provide a plausible explanation as to why P[6] RV strains are more common in Africa.
BACKGROUND: The live oral rotavirus (RV) vaccines have shown a reduced efficacy in Africa. Recent in vitro studies have shown binding of the RV surface protein (VP4) to histo-blood group antigens (HBGAs) in an RV genotype-dependent manner, suggesting them to be putative receptors for RV. The diversity of HBGA phenotypes in different ethnic populations, combined with prevalence/absence of specific RV genotypes, led us to hypothesize whether the genetic variations in HBGAs in a population limit susceptibility to certain RV genotypes, plausibly leading to reduced vaccine efficacy. METHODS: Association between HBGAs status and susceptibility to RV P genotypes was investigated in children in Burkina Faso and Nicaragua. In total, 242 children with diarrhea in Burkina Faso and Nicaragua were investigated, 93 of whom were RV positive. RESULTS: In Burkina Faso, the P[8] RV strains (n = 27) infected only Lewis- and secretor-positive children (27/27; P < .0001), but no Lewis-negative children. In contrast, the P[6] strains (n = 27) infected predominantly Lewis-negative children (n = 18; P < .0001) but also Lewis-positive children, irrespective of their secretor status. The results from Nicaragua confirmed that all P[8]-infected children (n = 22) were secretor Lewis positive. CONCLUSIONS: As VP4 of genotype P[8] is a component of current RV vaccines, our finding that Lewis-negative children are resistant to P[8] strains provides a plausible explanation for the reduced vaccine efficacy in populations with a high percentage of Lewis-negative individuals, such as in Africa. Furthermore, our findings provide a plausible explanation as to why P[6] RV strains are more common in Africa.
Authors: M Iturriza-Gómara; T Dallman; K Bányai; B Böttiger; J Buesa; S Diedrich; L Fiore; K Johansen; M Koopmans; N Korsun; D Koukou; A Kroneman; B László; M Lappalainen; L Maunula; A Mas Marques; J Matthijnssens; S Midgley; Z Mladenova; S Nawaz; M Poljsak-Prijatelj; P Pothier; F M Ruggeri; A Sanchez-Fauquier; A Steyer; I Sidaraviciute-Ivaskeviciene; V Syriopoulou; A N Tran; V Usonis; M VAN Ranst; A DE Rougemont; J Gray Journal: Epidemiol Infect Date: 2010-08-16 Impact factor: 2.451
Authors: Leon W Nitiema; Johan Nordgren; Djeneba Ouermi; Dayeri Dianou; Alfred S Traore; Lennart Svensson; Jacques Simpore Journal: Int J Infect Dis Date: 2011-07-16 Impact factor: 3.623
Authors: George E Armah; Samba O Sow; Robert F Breiman; Michael J Dallas; Milagritos D Tapia; Daniel R Feikin; Fred N Binka; A Duncan Steele; Kayla F Laserson; Nana A Ansah; Myron M Levine; Kristen Lewis; Michele L Coia; Margaret Attah-Poku; Joel Ojwando; Stephen B Rivers; John C Victor; Geoffrey Nyambane; Abraham Hodgson; Florian Schödel; Max Ciarlet; Kathleen M Neuzil Journal: Lancet Date: 2010-08-06 Impact factor: 79.321
Authors: Shabir A Madhi; Nigel A Cunliffe; Duncan Steele; Desirée Witte; Mari Kirsten; Cheryl Louw; Bagrey Ngwira; John C Victor; Paul H Gillard; Brigitte B Cheuvart; Htay H Han; Kathleen M Neuzil Journal: N Engl J Med Date: 2010-01-28 Impact factor: 91.245
Authors: Rebecca L Currier; Daniel C Payne; Mary A Staat; Rangaraj Selvarangan; S Hannah Shirley; Natasha Halasa; Julie A Boom; Janet A Englund; Peter G Szilagyi; Christopher J Harrison; Eileen J Klein; Geoffrey A Weinberg; Mary E Wikswo; Umesh Parashar; Jan Vinjé; Ardythe L Morrow Journal: Clin Infect Dis Date: 2015-03-05 Impact factor: 9.079
Authors: Sumit Sharma; Beatrice Carlsson; Rita Czakó; Sirkka Vene; Mats Haglund; Johnny Ludvigsson; Göran Larson; Lennart Hammarström; Stanislav V Sosnovtsev; Robert L Atmar; Kim Y Green; Mary K Estes; Lennart Svensson Journal: J Virol Date: 2017-06-26 Impact factor: 5.103
Authors: Joseph A Lewnard; Benjamin A Lopman; Umesh D Parashar; Naor Bar-Zeev; Prasanna Samuel; M Lourdes Guerrero; Guillermo M Ruiz-Palacios; Gagandeep Kang; Virginia E Pitzer Journal: J Infect Dis Date: 2017-08-01 Impact factor: 5.226